The novel piperazino-enaminone JOAB-40 reduced colitis severity in mice via inhibition tumor necrosis factor-α and interleukin-1β
Autor: | Khajah, Maitham A., Hawai, Sanaa, Szollosi, Doreen E., Bill, Ashley, Ghoneim, Ola, Edafiogho, Ivan |
---|---|
Zdroj: | In Biomedicine & Pharmacotherapy September 2021 141 |
Databáze: | ScienceDirect |
Externí odkaz: |